Search

everythinglearnresearchcommunity

for

Search:↓

Measuring minimal residual disease on day 15 helps identify high-risk leukemia patients.

Photobiomodulation is an effective and safe treatment for increasing hair growth in people with hair loss.

A woman developed a hair disorder after a bone marrow transplant, which improved with treatment.

ZSYY001 is safe, well-tolerated, and shows promise for treating advanced solid tumors.

Exposure to particulate matter worsens postpartum hair loss by affecting inflammation and cell death pathways.

Women with pituitary adenomas often have reproductive issues, like irregular periods and trouble getting pregnant, but not always breast milk production without pregnancy.

A new topical treatment using micelles shows promise for safer and more effective hair regrowth in androgenetic alopecia.

MK-2206 was safe and effectively blocked AKT signaling in cancer patients, warranting more trials.

Vepdegestrant may become the first FDA-approved PROTAC degrader, marking a new era in drug development.

Targeting the narrowest part of the anterior chamber angle may help prevent pupil block in glaucoma.

Redensyl, saw palmetto, and biotin with platelet-rich plasma is a better treatment for hair loss than Procapil with platelet-rich plasma.

IMTA can help regrow hair in severe alopecia areata when JAK inhibitors don't work well.

No current patient-reported outcome measure fully meets FDA requirements for alopecia treatments.

AMH levels can't reliably tell the difference between LOCAH and all types of PCOS in women with excessive hair growth.

Apremilast improved symptoms in patients with severe skin conditions.

A new treatment using AGED to modulate PPAR-γ shows promise for treating scarring hair loss by protecting and repairing hair follicle cells.

Ethinylestradiol/chlormadinone acetate may be an effective and well-tolerated treatment for skin conditions caused by excess androgens.

The document did not conclude on apremilast's effectiveness for severe alopecia areata.

Certain treatments, especially MZT1 and PRP2, effectively improve hair density and thickness in androgenetic alopecia.

Plant extracts can help remove permanent makeup without lasers.

New drugs and therapies targeting specific pathways show promise in treating advanced prostate cancer.

Multiphoton microscopy helps understand and improve vitiligo treatments by visualizing skin cell changes.

The MPV/PC ratio can help assess disease activity in alopecia areata.

Baricitinib helps regrow scalp, eyebrow, and eyelash hair in teens with severe alopecia areata.

Herbal products for benign prostate hypertrophy need better quality checks to ensure safety and effectiveness.

MC-DNA vector-based gene therapy can temporarily treat CBS deficiency in mice.

Apremilast was not effective in treating moderate-to-severe alopecia areata.